Redwood City, CA, United States of America

John Beaber

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.2

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: John Beaber: Innovator in Recombinant Polypeptide Compositions and Antibody Development

Introduction

John Beaber is a notable inventor based in Redwood City, CA (US). He holds 2 patents that showcase his contributions to the fields of recombinant polypeptide compositions and immune binding proteins. His work has significant implications for cancer treatment and the fight against SARS-CoV-2.

Latest Patents

One of Beaber's latest patents is titled "Release segments and binding compositions comprising same." This invention relates to activatable recombinant polypeptide compositions that include a cleavage release segment. These compositions are designed to bind effector T cells with targeted tumor or cancer cells, facilitating the cytolysis of these cells. The invention also outlines methods for making and using these cleavable activatable recombinant compositions.

Another significant patent is "Antibodies for SARS-CoV-2 and uses thereof." This disclosure focuses on immune binding proteins and methods for obtaining them from various sources. It specifically addresses anti-SARS-CoV-2 antibodies derived from individuals who have developed immunity to the virus. The patent also details methods for neutralizing SARS-CoV-2 and treatments utilizing these antibodies.

Career Highlights

Throughout his career, John Beaber has worked with several innovative companies, including Augmenta Biosciences, Inc. and Amunix Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in developing groundbreaking technologies.

Collaborations

Beaber has collaborated with notable professionals in his field, including Christopher J Emig and Rosanna Man Wah Chau. These partnerships have likely enhanced his research and development efforts.

Conclusion

John Beaber's contributions to the fields of recombinant polypeptide compositions and antibody development highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to addressing critical health challenges, particularly in cancer treatment and viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…